An Interval >7 Weeks between Neoadjuvant Therapy and Surgery Improves Pathologic Complete Response and Disease–Free Survival in Patients with Locally Advanced Rectal Cancer - Concepedia

Concepedia

Publication | Closed Access

An Interval >7 Weeks between Neoadjuvant Therapy and Surgery Improves Pathologic Complete Response and Disease–Free Survival in Patients with Locally Advanced Rectal Cancer

303

Citations

35

References

2008

Year

Hagit Tulchinsky, Einat Shmueli, Arié Figer, Joseph M. Klausner, Micha Rabau

Annals of Surgical Oncology

Disease–free SurvivalSurgical OncologyNeoadjuvant TherapyGastrointestinal OncologyColorectal SurgeryCancer RecurrenceMedicineSurgeryCancer TreatmentOncologyRadiation OncologyCancer Research

References

	Year	Citations

Page 1